- Home
- BBD vs STE Comparison
BBD vs STE Comparison
Compare BBD & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBD
- STE
- Stock Information
- Founded
- BBD 1943
- STE 1985
- Country
- BBD Brazil
- STE United States
- Employees
- BBD N/A
- STE N/A
- Industry
- BBD Major Banks
- STE Industrial Specialties
- Sector
- BBD Finance
- STE Health Care
- Exchange
- BBD Nasdaq
- STE Nasdaq
- Market Cap
- BBD 30.6B
- STE 23.0B
- IPO Year
- BBD N/A
- STE 1992
- Fundamental
- Price
- BBD $3.30
- STE $248.80
- Analyst Decision
- BBD Strong Buy
- STE Buy
- Analyst Count
- BBD 4
- STE 9
- Target Price
- BBD $2.55
- STE $268.25
- AVG Volume (30 Days)
- BBD 36.0M
- STE 511.8K
- Earning Date
- BBD 10-30-2025
- STE 11-05-2025
- Dividend Yield
- BBD 4.70%
- STE 0.91%
- EPS Growth
- BBD 58.81
- STE 61.94
- EPS
- BBD 0.36
- STE 6.53
- Revenue
- BBD $16,114,445,927.00
- STE $5,571,115,000.00
- Revenue This Year
- BBD $72.65
- STE $9.24
- Revenue Next Year
- BBD $8.90
- STE $6.05
- P/E Ratio
- BBD $8.29
- STE $38.37
- Revenue Growth
- BBD 27.09
- STE 6.42
- 52 Week Low
- BBD $1.84
- STE $200.98
- 52 Week High
- BBD $3.34
- STE $253.00
- Technical
- Relative Strength Index (RSI)
- BBD 70.43
- STE 56.34
- Support Level
- BBD $3.11
- STE $246.96
- Resistance Level
- BBD $3.22
- STE $253.00
- Average True Range (ATR)
- BBD 0.07
- STE 4.37
- MACD
- BBD 0.01
- STE -0.25
- Stochastic Oscillator
- BBD 89.47
- STE 69.12
About BBD Banco Bradesco Sa
Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.